2014
DOI: 10.1038/bjc.2013.822
|View full text |Cite
|
Sign up to set email alerts
|

G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration

Abstract: Background:Granulocyte colony-stimulating factor (G-CSF) is a pro-inflammatory cytokine that stimulates myeloid stem cell maturation, proliferation, and migration into circulation. Despite being a known growth factor, the impact of G-CSF on solid tumours has not been well examined. G-CSF receptor (G-CSFR) is expressed by some tumours, and thus the aim of this study was to examine the expression and impact of G-CSF and G-CSFR on gastrointestinal tumours.Methods:In this study, G-CSF expression was examined in hu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

9
90
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(99 citation statements)
references
References 38 publications
9
90
0
Order By: Relevance
“…Although G-CSF behaves as a potent migratory stimulus for haematopoietic cells [48], just a moderate effect was observed in Swan 71 cells. In this regard, it should be considered that a wide range of G-CSF migratory potencies has been reported in non-haematopoietic tissues, being slight responses (up to 1.4-fold increase) induced in glioma cells [7] and head and neck squamous cell carcinomas [8], and more pronounced effects (up to 6-fold increase) observed in rat oval cells [49] and gastric and colon cancer cells [50]. In spite of the differences observed in the G-CSF-migratory potency, this cytokine might be considered as a promoting factor for cell migration, while other G-CSF-mediated biological effects, such as the proliferative and survival responses, seem to be more restricted to some cell types.…”
Section: Discussionmentioning
confidence: 99%
“…Although G-CSF behaves as a potent migratory stimulus for haematopoietic cells [48], just a moderate effect was observed in Swan 71 cells. In this regard, it should be considered that a wide range of G-CSF migratory potencies has been reported in non-haematopoietic tissues, being slight responses (up to 1.4-fold increase) induced in glioma cells [7] and head and neck squamous cell carcinomas [8], and more pronounced effects (up to 6-fold increase) observed in rat oval cells [49] and gastric and colon cancer cells [50]. In spite of the differences observed in the G-CSF-migratory potency, this cytokine might be considered as a promoting factor for cell migration, while other G-CSF-mediated biological effects, such as the proliferative and survival responses, seem to be more restricted to some cell types.…”
Section: Discussionmentioning
confidence: 99%
“…Tumor-related leukocytosis is observed in 10% of patients with solid tumors and is associated with poor clinical outcome (3). This condition is caused, in part, by granulocyte colony-stimulating factor (G-CSF) synthesized by neoplastic cells and has therefore been regarded as potentially indicative of the autocrine stimulation of tumor growth by G-CSF (4,5). However, little is known regarding the precise mechanisms of aggressive behavior and poor outcome in G-CSF-producing tumors.…”
Section: Introductionmentioning
confidence: 99%
“…G-CSFR, a critical regulator of granulopoiesis, has been reported to play a pivotal role in tumorigenesis [80-82]. To this end, it has been shown that G-CSF/G-CSFR, though both autocrine and paracrine mechanism, enhanced cell survival and promoted cell growth in bladder cancer cells [83].…”
Section: Introductionmentioning
confidence: 99%